These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
¨
|
Preliminary Proxy Statement
|
|
¨
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
ý
|
Definitive Proxy Statement
|
|
¨
|
Definitive Additional Materials
|
|
¨
|
Soliciting Material under §240.14a-12
|
|
ý
|
No fee required.
|
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
5)
|
Total fee paid:
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
1)
|
Amount Previously Paid:
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
3)
|
Filing Party:
|
|
4)
|
Date Filed:
|
|
1.
|
To elect four Class II directors named in the accompanying proxy statement (Proposal One);
|
|
2.
|
To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020 (Proposal Two);
|
|
3.
|
To vote, on an advisory basis, on the frequency of future advisory votes on executive compensation (Proposal Three);
|
|
4.
|
To transact such other business as may properly come before the annual meeting.
|
|
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON MAY 21, 2020 AT 9:00 A.M. CENTRAL TIME IN A LIVE WEBCAST AT www.virtualshareholdermeeting.com/SWI2020: THIS PROXY STATEMENT AND 2019 ANNUAL REPORT ARE AVAILABLE AT
www.proxyvote.com
.
|
|
•
|
By Internet.
To vote by proxy through the Internet, go to
www.proxyvote.com
to complete an electronic proxy card. You will be asked to provide the company number and control number included on the enclosed proxy card. To be counted, we must receive your vote by 11:59 p.m. Eastern Time on
May 20, 2020
, the day prior to the annual meeting.
|
|
•
|
By telephone.
To vote by proxy over the telephone, dial toll-free, 1-800-690-6903, using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and control number included on the enclosed proxy card. To be counted, we must receive your vote by 11:59 p.m. Eastern Time on
May 20, 2020
, the day prior to the annual meeting.
|
|
•
|
By mail.
To vote using the enclosed proxy card, simply complete, sign, date, and return it promptly in the envelope provided. To be counted, we must receive your signed proxy card by 11:59 p.m. Eastern Time on
May 20, 2020
, the day prior to the annual meeting.
|
|
•
|
At the annual meeting.
To vote virtually during the live webcast of the annual meeting, please follow the instructions for attending and voting at the annual meeting posted at
www.virtualshareholdermeeting.com/SWI2020
. You will need the company number and control number included on the enclosed proxy card. All votes must be received by the inspectors of election appointed for the meeting before the polls close at the annual meeting.
|
|
•
|
submitting a subsequent proxy by using the Internet, by telephone or by mail with a later date;
|
|
•
|
sending a timely written notice of revocation to Corporate Secretary, SolarWinds Corporation, 7171 Southwest Parkway, Building 400, Austin, Texas 78735; or
|
|
•
|
attending the annual meeting and voting virtually during the live webcast.
|
|
•
|
submitting new voting instructions in the manner provided by your bank, broker or other holder of record; or
|
|
•
|
obtaining a “legal proxy” from your bank, broker or other holder of record in order to vote your shares virtually at the annual meeting.
|
|
•
|
the election of
four
Class
II
directors nominated by the Board and named in the proxy statement to serve a term of three years until our
2023
annual meeting of stockholders (Proposal One);
|
|
•
|
the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending
December 31, 2020
(Proposal Two); and
|
|
•
|
on an advisory basis, the frequency of future advisory votes on executive compensation (Proposal Three).
|
|
•
|
vote FOR the election of the director nominee; or
|
|
•
|
vote WITHHOLD with respect to the election of the director nominee.
|
|
•
|
reduce the number of directors that serve on the Board; or
|
|
•
|
designate a substitute nominee.
|
|
•
|
vote FOR the proposal;
|
|
•
|
vote AGAINST the proposal; or
|
|
•
|
ABSTAIN from voting on the proposal.
|
|
•
|
vote for the advisory vote to be held every ONE year;
|
|
•
|
vote for the advisory vote to be held every TWO years;
|
|
•
|
vote for the advisory vote to be held every THREE years; or
|
|
•
|
ABSTAIN from voting on the proposal.
|
|
•
|
FOR each of the director nominees;
|
|
•
|
FOR the ratification of the appointment of our independent registered public accounting firm; and
|
|
•
|
for ONE year as the frequency of future advisory votes on executive compensation.
|
|
•
|
indicate when voting on the Internet or by telephone that you wish to vote as recommended by the Board; or
|
|
•
|
sign and return a proxy card without giving specific voting instructions,
|
|
•
|
Proposal One
: Abstentions and broker non-votes will not count as a vote “FOR” or “AGAINST” with respect to a nominee’s election and thus will not be counted in determining the outcome of the election of directors.
|
|
•
|
Proposal Two
: Abstentions will be counted towards the vote total and will have the same effect as votes against this proposal. The approval of Proposal Two is a routine matter on which a broker is generally empowered to vote. Because the approval of this proposal is a routine matter on which a broker is generally empowered to vote, if you do not submit voting instructions, your broker may exercise its discretion to vote your shares on this proposal.
|
|
•
|
Proposal Three
: Abstentions and broker non-votes will not be counted in determining the outcome of the vote on Proposal Three. Because this vote is advisory and non-binding, if none of the frequency options receives a majority of the votes, the choice receiving the greatest number of votes will be considered the frequency recommended by the Company’s stockholders.
|
|
Name
|
|
Age
|
|
Positions and Offices Held with Company
|
|
Director Since
|
|
Catherine R. Kinney
|
|
68
|
|
Director
|
|
October 2018
|
|
James Lines
|
|
63
|
|
Director
|
|
February 2016
|
|
Easwaran Sundaram
|
|
49
|
|
Director
|
|
February 2020
|
|
Michael Widmann
|
|
31
|
|
Director
|
|
February 2020
|
|
Name
|
|
Age
|
|
Positions and Offices Held with Company
|
|
Director Since
|
|
Kevin B. Thompson
|
|
54
|
|
President, Chief Executive Officer and Director
|
|
February 2016
|
|
Mike Bingle
|
|
47
|
|
Director
|
|
February 2016
|
|
William Bock
|
|
69
|
|
Director
|
|
October 2018
|
|
Seth Boro
|
|
44
|
|
Director
|
|
February 2016
|
|
Paul J. Cormier
|
|
62
|
|
Director
|
|
October 2018
|
|
Kenneth Y. Hao
|
|
51
|
|
Director
|
|
February 2016
|
|
Michael Hoffmann
|
|
34
|
|
Director
|
|
October 2018
|
|
Our Board recommends that you vote FOR Ms. Kinney and Messrs. Lines, Sundaram and Widmann.
|
|
•
|
so long as the Silver Lake Funds own, in the aggregate, (i) at least 20% of the aggregate number of outstanding shares of common stock immediately following the consummation of our initial public offering, or IPO, affiliates of Silver Lake will be entitled to nominate three directors, (ii) less than 20% but at least 10% of the aggregate number of outstanding shares of common stock immediately following the consummation of our IPO, affiliates of Silver Lake will be entitled to nominate two directors, and (iii) less than 10% but at least 5% of the aggregate number of outstanding shares of common stock immediately following the consummation of our IPO, affiliates of Silver Lake will be entitled to nominate one director; and
|
|
•
|
so long as the Thoma Bravo Funds and their co-investors own, in the aggregate, (i) at least 20% of the aggregate number of outstanding shares of common stock immediately following the consummation of our IPO, affiliates of Thoma Bravo will be entitled to nominate three directors, (ii) less than 20% but at least 10% of the aggregate number of outstanding shares of common stock immediately following the consummation of our IPO, affiliates of Thoma Bravo will be entitled to nominate two directors, and (iii) less than 10% but at least 5% of the aggregate number of outstanding shares of common stock immediately following the consummation of our IPO, affiliates of Thoma Bravo will be entitled to nominate one director.
|
|
Name
|
|
Audit Committee
|
|
Compensation Committee
|
|
Nominating and Corporate Governance Committee
|
|
Mike Bingle
|
|
|
|
|
|
Member
|
|
William Bock
|
|
Chair
|
|
Chair
|
|
|
|
Seth Boro
|
|
|
|
Member
|
|
|
|
Paul J. Cormier
|
|
|
|
|
|
Member
|
|
Kenneth Y. Hao
|
|
|
|
Member
|
|
|
|
Catherine Kinney
|
|
Member
|
|
|
|
Chair
|
|
Easwaran Sundaram
|
|
Member
|
|
|
|
|
|
•
|
selecting a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;
|
|
•
|
helping to ensure the independence and performance of the independent registered public accounting firm;
|
|
•
|
discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and that firm, our interim and year-end operating results;
|
|
•
|
establishing procedures for employees to submit concerns anonymously about questionable accounting or audit matters;
|
|
•
|
considering the adequacy of our internal controls and internal audit function;
|
|
•
|
reviewing material related-party transactions or those that require disclosure; and
|
|
•
|
approving or, as permitted, pre-approving all audit and non-audit services to be performed by the independent registered public accounting firm.
|
|
•
|
reviewing and approving, or recommending that our Board approve, the compensation of our executive officers;
|
|
•
|
reviewing and recommending to our Board the compensation of our directors;
|
|
•
|
reviewing and recommending to our Board the terms of any compensatory agreements with our executive officers;
|
|
•
|
administering our stock and equity incentive plans;
|
|
•
|
reviewing and approving, or making recommendations to our Board with respect to, incentive compensation and equity plans; and
|
|
•
|
reviewing our overall compensation philosophy.
|
|
•
|
identifying and recommending candidates for membership on our Board, in accordance with the terms and requirements of the stockholders’ agreement;
|
|
•
|
reviewing and recommending our corporate governance guidelines and policies;
|
|
•
|
reviewing proposed waivers of the code of business conduct and ethics for directors and executive officers;
|
|
•
|
overseeing the process of evaluating the performance of our Board;
|
|
•
|
overseeing our general risk management strategy;
|
|
•
|
establishing and reviewing compliance with stock ownership guidelines for the Company’s executive officers and non-employee directors; and
|
|
•
|
assisting our Board on corporate governance matters.
|
|
•
|
the name of the stockholder and evidence of the person’s ownership of our stock, including the number of shares owned and the length of time that the person has owned the shares;
|
|
•
|
the name of the candidate, the candidate’s resume or a listing of his or her qualifications to be a director;
|
|
•
|
the written consent of the proposed candidate to be named as a nominee and to serve as a director if elected; and
|
|
•
|
any other information about the stockholder and the candidate that would be required if the stockholder provided notice to the Company of its intent to nominate the director candidate pursuant to Section 3.16 of our bylaws.
|
|
Name
|
|
Fees Earned or Paid in Cash
(1)
($)
|
|
Stock Awards
(2)
($)
|
|
All Other Compensation
($)
|
|
Total
($)
|
||||
|
Michael Bingle
|
|
55,000
|
|
|
209,986
|
|
|
—
|
|
|
264,986
|
|
|
William Bock
|
|
92,500
|
|
|
209,986
|
|
|
—
|
|
|
302,486
|
|
|
Seth Boro
|
|
58,750
|
|
|
209,986
|
|
|
—
|
|
|
268,736
|
|
|
Paul J. Cormier
(3)
|
|
57,548
|
|
|
209,986
|
|
|
—
|
|
|
267,534
|
|
|
Kenneth Y. Hao
|
|
58,750
|
|
|
209,986
|
|
|
—
|
|
|
268,736
|
|
|
Michael Hoffmann
|
|
50,000
|
|
|
209,986
|
|
|
—
|
|
|
259,986
|
|
|
Catherine R. Kinney
(4)
|
|
91,701
|
|
|
209,986
|
|
|
—
|
|
|
301,687
|
|
|
James Lines
(5)
|
|
59,986
|
|
|
209,986
|
|
|
—
|
|
|
269,972
|
|
|
Easwaran Sundaram
(6)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Jason White
(7)
|
|
50,833
|
|
|
209,986
|
|
|
—
|
|
|
260,819
|
|
|
Michael Widmann
(8)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1)
|
The amounts in this column represent the amounts paid to our non-employee directors for board and committee service during the fiscal year ended
December 31, 2019
under our non-employee director compensation policy, which is further described below under the caption “
Narrative Disclosure to Director Compensation Table—Non-Employee Director Compensation Policy
.”
|
|
(2)
|
The amounts reported in this column reflect the aggregate grant date fair value of restricted stock units, or RSUs, using the closing price of a share of common stock on the grant date computed in accordance with ASC Topic 718. The RSUs were the annual equity grants under our non-employee director compensation policy that were granted on the date of our 2019 annual meeting of stockholders as further described below under the caption “
Narrative Disclosure to Director Compensation Table—Non-Employee Director Compensation Policy
.” The number of shares of common stock underlying outstanding stock awards held by each of our non-employee directors as of
December 31, 2019
is as follows:
|
|
Director Name
|
|
Outstanding Stock Awards
|
|
|
Michael Bingle
|
|
33,852
|
|
|
William Bock
|
|
33,852
|
|
|
Seth Boro
|
|
33,852
|
|
|
Paul J. Cormier
|
|
33,852
|
|
|
Kenneth Y. Hao
|
|
33,852
|
|
|
Michael Hoffmann
|
|
33,852
|
|
|
Catherine R. Kinney
|
|
33,852
|
|
|
James Lines
|
|
45,519
|
|
|
Easwaran Sundaram
|
|
—
|
|
|
Jason White
(7)
|
|
33,852
|
|
|
Michael Widmann
|
|
—
|
|
|
(3)
|
Includes pro rata audit committee member retainer for period during which Mr. Cormier served on our audit committee during 2019 (from October 18, 2019 to December 31, 2019).
|
|
(4)
|
Includes pro rata audit committee member retainer for period during which Ms. Kinney served on our audit committee during 2019 (from January 24, 2019 to December 31, 2019).
|
|
(5)
|
Includes pro rata audit committee member retainer for period during which Mr. Lines served on our audit committee during 2019 (from January 1, 2019 to October 18, 2019).
|
|
(6)
|
Mr. Sundaram was appointed as a director effective on February 25, 2020 and did not receive any compensation from us during the fiscal year ended
December 31, 2019
.
|
|
(7)
|
Includes pro rata audit committee member retainer for period during which Mr. White served on our audit committee during 2019 (from January 1, 2019 to January 24, 2019). Mr. White resigned as a director effective on February 26, 2020. Mr. White will provide consulting services to the Company from February 2020 until the date of the Company’s 2020 annual stockholder meeting, during which period Mr. White’s outstanding equity awards will continue to vest.
|
|
(8)
|
Mr. Widmann was appointed as a director effective on February 26, 2020 and did not receive any compensation from us during the fiscal year ended
December 31, 2019
.
|
|
•
|
attract world class business talent, experienced with fast-growing multinationals in the technology sector;
|
|
•
|
provide compensation that is competitive relative to our industry, size, and complexity;
|
|
•
|
differentiate for roles with added experience requirements and / or time commitments; and
|
|
•
|
align program design to focus decision-making on long-term stockholder value creation.
|
|
General Board member retainer
|
|
$50,000
|
|
Lead Independent Director retainer
|
|
$20,000
|
|
Audit Committee Chair retainer
|
|
$25,000
|
|
Compensation Committee Chair retainer
|
|
$17,500
|
|
Nominating and Corporate Governance Committee Chair retainer
|
|
$10,000
|
|
Audit Committee member retainer
|
|
$12,500
|
|
Compensation Committee member retainer
|
|
$8,750
|
|
Nominating and Corporate Governance Committee member retainer
|
|
$5,000
|
|
Initial equity grant
|
|
$460,000 value (100% RSUs)
(1)
|
|
Annual equity grant
(2)
|
|
$210,000 (100% RSUs)
(3)
|
|
|
|
(1)
|
The number of RSUs granted will be calculated using the closing price of one share of our common stock on the grant date. The awards vest annually over four years with 25% of the RSUs vesting on each anniversary of the grant date, subject to continued service through each applicable date, unless otherwise determined by the Board and set forth in the grant agreement between the non-employee director and the Company.
|
|
(2)
|
The annual equity grant is awarded to continuing directors on each date of the Company’s annual meeting of stockholders if, as of such date, a director has served on the Board for at least the preceding six months.
|
|
(3)
|
The number of RSUs granted will be calculated using the closing price of one share of our common stock on the grant date. The award will vest 100% on the one-year anniversary of the grant date, subject to continued service through such date.
|
|
|
|
2019
|
|
2018
|
||||
|
Audit Fees
|
|
$
|
2,382,000
|
|
|
$
|
1,980,000
|
|
|
Audit-Related Fees
|
|
—
|
|
|
—
|
|
||
|
Tax Fees
|
|
379,397
|
|
|
380,129
|
|
||
|
Other Fees
|
|
900
|
|
|
975
|
|
||
|
Total
|
|
$
|
2,762,297
|
|
|
$
|
2,361,104
|
|
|
Our Board recommends that you vote FOR the proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.
|
|
•
|
reviewed and discussed with management the Company’s audited financial statements for the year ended
December 31, 2019
;
|
|
•
|
discussed with PricewaterhouseCoopers LLP the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (PCAOB) and the SEC; and
|
|
•
|
received and reviewed the written disclosures and the letter from PricewaterhouseCoopers LLP required by applicable requirements of the PCAOB regarding PricewaterhouseCooper LLP’s communications with the audit committee concerning independence, and the audit committee has discussed with PricewaterhouseCoopers LLP that firm’s independence.
|
|
Our Board recommends that you vote
“
ONE YEAR
”
as the frequency for
advisory votes on executive compensation.
|
|
Name
|
|
Age
|
|
Position
|
|
Kevin B. Thompson
|
|
54
|
|
President and Chief Executive Officer
|
|
J. Barton Kalsu
|
|
52
|
|
Executive Vice President, Chief Financial Officer and Treasurer
|
|
David Gardiner
|
|
44
|
|
Executive Vice President and President, ITOM
|
|
Jason W. Bliss
|
|
45
|
|
Executive Vice President, Corporate Development, General Counsel and Secretary
|
|
Woong Joseph Kim
|
|
41
|
|
Executive Vice President, Engineering and Chief Technology Officer
|
|
John Pagliuca
|
|
43
|
|
Executive Vice President and President, MSP
|
|
•
|
Compensation Discussion and Analysis;
|
|
•
|
Reporting of compensation information for two additional executive officers listed as named executive officers, referred to as our NEOs;
|
|
•
|
An additional year of reporting history in our Summary Compensation Table;
|
|
•
|
Additional compensation disclosure tables for “Grants of Plan-Based Awards”, “Option Exercises and Stock Vested,” and “Potential Payments upon Termination or Change in Control”; and
|
|
•
|
A non-binding advisory vote on the frequency of future advisory votes on executive compensation, which is Proposal Three of this proxy statement.
|
|
NEO
|
|
Position
|
|
Kevin B. Thompson
|
|
President and Chief Executive Officer
|
|
J. Barton Kalsu
|
|
Executive Vice President, Chief Financial Officer and Treasurer
|
|
David Gardiner
|
|
Executive Vice President and President, ITOM
|
|
Jason W. Bliss
|
|
Executive Vice President, Corporate Development, General Counsel and Secretary
|
|
Woong Joseph Kim
|
|
Executive Vice President, Engineering and Chief Technology Officer
|
|
•
|
Base salaries for our NEOs increased between 8% and 12%.
|
|
•
|
The 2019 Executive Bonus Plan resulted in a formulaic payout of 70% based on 2019 achievement against corporate objectives for revenue and adjusted EBITDA. For 2019, the compensation committee decided to exercise discretion to increase the payout to 80%.
|
|
•
|
All of our NEOs received equity awards at the time of our IPO in October 2018. As a result, we did not issue annual equity awards to our NEOs in 2019. We resumed our annual equity grant practice in the first quarter of 2020.
|
|
•
|
Certain performance equity awards granted in prior fiscal years were subject to vesting based on meeting revenue and adjusted EBITDA performance objectives for fiscal year 2019.
|
|
◦
|
Previously granted restricted shares subject to 2019 performance were achieved at 70% and vested upon certification. The 30% of such shares that were not achieved will carry forward for potential vesting following fiscal 2020, pursuant to the terms of the applicable award agreements.
|
|
◦
|
Previously granted performance stock units, or PSUs, subject to 2019 performance were achieved at 70%, with the achieved portions of such awards continuing to vest through 2022. The 30% of the PSUs that were not achieved were forfeited. The compensation committee decided to issue new awards for the forfeited PSUs, which will potentially vest following fiscal 2020 based on achievement of performance metrics for fiscal 2020.
|
|
•
|
The performance objectives for compensation subject to 2019 performance were adjusted on a pro-forma basis for our larger acquisitions
—
specifically, Samanage in May 2019
—
in order to maintain the same likelihood of achievement immediately prior to and preceding such acquisitions. We did not adjust performance objectives for acquisitions that did not materially impact our pro-forma objectives for the year.
|
|
•
|
In 2019, our nominating and corporate governance committee adopted stock ownership guidelines for our Chief Executive Officer equal to five times his annual salary, and the other executive officers equal to three times their respective salary. Executive officers have five years to attain the required level of ownership.
|
|
|
Cash Compensation
|
Equity Compensation
|
Other
|
|||
|
|
Base Salary
|
Executive Bonus Plan
|
Performance Stock Units
|
Restricted Stock Units
|
Broad-Based Benefits
|
|
|
Primary Purpose
|
Attraction and Retention
|
|||||
|
----
|
Reward Short-Term Performance
|
Reward Long-Term Performance
Align Interests with Shareholder
|
---
|
|||
|
Recipients
|
All NEOs
|
|||||
|
Reviewed
|
Annually
|
|||||
|
Grant Date
|
---
|
First Quarter for Current Year
|
---
|
|||
|
Payment Date
|
Ongoing
|
First Quarter of Next Fiscal Year
|
Vesting over
3 Years
|
Vesting over
4 Years
|
Ongoing
|
|
|
Fixed or At-Risk
|
Fixed
|
Variable or At-Risk
|
Fixed
|
|||
|
Performance Period
|
---
|
1 Year
|
1 Year
|
---
|
---
|
|
|
Performance Basis
|
Compensation Committee judgment
|
Revenue and EBITDA growth formulaic funding, plus Compensation Committee judgment
|
Subject to stock price fluctuations
|
---
|
||
|
What We Do
|
|
|
What We Don't Do
|
|
|
ü
|
Pay for performance through incentives based on Company performance
|
|
û
|
Guarantee annual salary increases or bonuses
|
|
ü
|
Align executive compensation with stockholder returns through long-term incentives
|
|
û
|
Tax gross-ups or perquisites except with respect to the standard benefits that are provided to all Company employees or as part of an international assignment
|
|
ü
|
Structure executive officer compensation so the majority of compensation is at-risk
|
|
û
|
Excise tax gross-ups for executive officers in the event of a change in control
|
|
ü
|
Annual and ongoing reviews of compensation programs, practices, policies, and governance, including assessment to mitigate undue risk taking by executives
|
|
û
|
Allow hedging or pledging of Company stock
|
|
ü
|
Require double-trigger for potential payments upon a change in control in any new compensation arrangements
|
|
û
|
Make pension arrangements or separate executive retirement plans for NEOs
|
|
ü
|
Maintain stock ownership requirements and guidelines
|
|
|
|
|
Objective
|
|
Description
|
|
Competitive Pay
|
|
Our total compensation program is designed to be competitive to recruit and retain highly qualified executives for critical positions.
|
|
Balanced Pay Mix
|
|
Our compensation program is a combination of short- and long-term, cash and equity, and fixed and performance-based components. A majority of our executive compensation program is performance-based and ‘at-risk,’ or otherwise focused on the long-term, which we believe aligns our executive officers’ interests with stockholders.
|
|
Pay for Performance
|
|
The compensation package is designed to link short- and long-term incentives to the Company’s performance against operational goals to motivate and drive execution against our operational goals.
|
|
Stockholder Alignment
|
|
The compensation package is designed to link long-term incentives to the creation of stockholder value to align the interests of our management with those of our stockholders and drive the creation of long-term stockholder value.
|
|
Balanced Performance
Management
|
|
We use a combination of financial performance metrics, varying time horizons, and compensation vehicles to provide a balanced and comprehensive measure of performance, and to encourage effective use of resources to achieve corporate objectives.
|
|
Manage Compensation Risk
|
|
We set incentive goals in such a way as to discourage excessive risk taking and avoid placing too much emphasis on any one metric or performance time horizon.
|
|
NEO
|
|
2018 Base Salary
|
|
2019 Base Salary
|
|
% Change
|
|||
|
Kevin B. Thompson
(1)
|
|
625,000
|
|
|
700,000
|
|
|
12.0
|
%
|
|
J. Barton Kalsu
|
|
380,000
|
|
|
425,000
|
|
|
11.8
|
%
|
|
David Gardiner
|
|
375,000
|
|
|
417,500
|
|
|
11.3
|
%
|
|
Jason W. Bliss
|
|
360,000
|
|
|
390,000
|
|
|
8.3
|
%
|
|
Woong Joseph Kim
|
|
360,000
|
|
|
390,000
|
|
|
8.3
|
%
|
|
(1)
|
The salary increase for Mr. Thompson was considered in conjunction with the decrease in his annual bonus target detailed below under “
Executive Bonus Plan.
”
|
|
NEO
|
|
2018 Target Bonus
|
|
2019 Target Bonus
|
|
% Change
|
||||
|
Kevin B. Thompson
(1)
|
|
135
|
%
|
|
125
|
%
|
|
(10
|
)%
|
|
|
J. Barton Kalsu
|
|
80
|
%
|
|
80
|
%
|
|
—
|
%
|
|
|
David Gardiner
|
|
$
|
375,000
|
|
|
100
|
%
|
|
—
|
%
|
|
Jason W. Bliss
|
|
80
|
%
|
|
80
|
%
|
|
—
|
%
|
|
|
Woong Joseph Kim
|
|
80
|
%
|
|
80
|
%
|
|
—
|
%
|
|
|
(1)
|
The bonus target decrease for Mr. Thompson was considered in conjunction with the increase in his annual base salary detailed above under “
Base Salary
.”
|
|
|
|
Revenue
(30% Weighting)
|
|
Adjusted EBITDA
(70% Weighting)
|
||||
|
Performance Level
|
|
Achievement (% of Target)
|
|
Payout
(% of Target) |
|
Achievement (% of Target)
|
|
Payout
(% of Target) |
|
Threshold
|
|
97.6%
|
|
50%
|
|
97.4%
|
|
50%
|
|
Midpoint
|
|
98.2%
|
|
75%
|
|
98.5%
|
|
75%
|
|
Target
|
|
100.0%
|
|
100%
|
|
100.0%
|
|
100%
|
|
Revenue Performance Gate
|
|
Upside Component Funding
|
|
At least 98.2% of Target but less than 99.2% of Target
|
|
One-third of adjusted EBITDA in excess of Target
|
|
At least 99.2% of Target
|
|
One-half of adjusted EBITDA in excess of Target
|
|
•
|
PSUs are designed to incentivize actions that lead to increasing long-term stockholder value. Performance objectives underlying the PSUs are generally determined at the time of grant and may include multiple performance factors, performance periods of varying length, potential to earn above or below the target number of shares based on actual performance, or additional service vesting criteria. The number of PSUs ultimately earned by executives is subject to achievement against the performance objectives with the value of the underlying shares varying with the Company’s stock price over the vesting period. PSUs granted to our NEOs typically vest over three years, with the first tranche vesting on the date that the compensation committee certifies achievement against the applicable performance metrics and the remaining tranches vesting in February of the following two years, subject to continued service through each applicable date.
|
|
•
|
RSUs are linked with stockholder value since the value of RSU grants rise or fall with the stock price. RSUs are also intended to encourage retention as they are subject to vesting. RSUs granted to our NEOs typically vest over four years, subject to continued service through each applicable date.
|
|
•
|
2016 Plan Awards
. Prior to our IPO, we granted restricted shares to our NEOs for purchase at the then-current fair market value under the SolarWinds Corporation Equity Plan, or the 2016 Plan, which were subject to vesting based on performance objectives for future years or subject to repurchase at the lesser of the original purchase price or the then-current fair market value if vesting did not eventually occur. We granted Messrs. Thompson, Kalsu, Gardiner and Bliss restricted shares in September 2016 and Mr. Kim restricted shares in August 2016 and October 2017, which included vesting tranches that were subject to 2019 performance. For 2019, revenue was weighted at 30% of the total number of shares eligible to vest for 2019 performance, and adjusted EBITDA was weighted at 70%. There was no upside component to the awards under the 2016 Plan for performance above the target. Any portion of such shares that did not vest based on 2019 performance would remain eligible to vest if the Company met performance objectives established by the compensation committee in the following fiscal year.
|
|
•
|
2018 Plan Awards
. In October 2018 in connection with our IPO, we granted PSUs to our NEOs under the 2018 Plan, which were subject to vesting based on achievement of revenue and adjusted EBITDA objectives for 2019. Up to 30% of the target number of PSUs could be earned based on achievement against revenue objectives, and up to 70% of the target number of PSUs could be earned based on achievement against adjusted EBITDA objectives for 2019. An additional 50% of the target number of PSUs could be earned based on performance above the revenue objectives provided that at least 98.5% of the adjusted EBITDA target was also achieved. This additional component of the PSUs was revenue-based to incentivize growth in our business and market share expansion, which we believe is highly correlated to long-term stockholder value creation. Any PSUs achieved based on 2019 performance would vest in three equal installments
—
upon certification of performance, in February 2021, and in February 2022, subject
|
|
•
|
Supports the achievement of revenue growth, earnings and cash performance in variable economic and industry conditions without undue risk; and
|
|
•
|
Mitigates the potential to reward risk-taking that may produce short-term results that appear in isolation to be favorable, but that may undermine the successful execution of the Company’s long-term business strategy and harm stockholder value.
|
|
Name and Principal Position
|
|
Year
|
|
Salary
($)
|
|
Bonus
(1)
($)
|
|
Stock
Awards
(2)
($)
|
|
Non-equity
Incentive Plan
Compensation
(3)
($)
|
|
All Other
Compensation
(4)
($)
|
|
Total
($)
|
||||||
|
Kevin B. Thompson
|
|
2019
|
|
700,000
|
|
|
87,500
|
|
|
—
|
|
|
612,500
|
|
|
11,200
|
|
|
1,411,200
|
|
|
President and Chief Executive Officer
|
|
2018
|
|
625,000
|
|
|
—
|
|
|
7,341,824
|
|
|
734,063
|
|
|
11,000
|
|
|
8,711,887
|
|
|
|
|
2017
|
|
625,000
|
|
|
42,188
|
|
|
—
|
|
|
675,000
|
|
|
10,800
|
|
|
1,352,988
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
J. Barton Kalsu
|
|
2019
|
|
425,000
|
|
|
34,000
|
|
|
—
|
|
|
238,000
|
|
|
11,200
|
|
|
708,200
|
|
|
Executive Vice President, Chief Financial Officer and Treasurer
|
|
2018
|
|
380,000
|
|
|
—
|
|
|
2,273,600
|
|
|
264,480
|
|
|
11,000
|
|
|
2,929,080
|
|
|
|
|
2017
|
|
380,000
|
|
|
15,200
|
|
|
—
|
|
|
243,200
|
|
|
10,800
|
|
|
649,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
David Gardiner
|
|
2019
|
|
417,500
|
|
|
41,750
|
|
|
—
|
|
|
218,400
|
|
|
68,935
(5),(6)
|
|
|
820,435
|
|
|
Executive Vice President and President, ITOM
|
|
2018
|
|
370,833
|
|
|
—
|
|
|
2,557,800
|
|
|
322,625
|
|
|
230,390
(7)
|
|
|
3,481,648
|
|
|
|
|
2017
|
|
325,000
|
|
|
16,250
|
|
|
—
|
|
|
260,000
|
|
|
284,731
(8)
|
|
|
885,981
|
|
|
Jason W. Bliss
(9)
|
|
2019
|
|
390,000
|
|
|
31,200
|
|
|
—
|
|
|
218,400
|
|
|
11,200
|
|
|
650,800
|
|
|
Executive Vice President, Corporate Development, General Counsel and Secretary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Woong Joseph Kim
(10)
|
|
2019
|
|
390,000
|
|
|
31,200
|
|
|
|
|
218,400
|
|
|
61,203
(11)
|
|
|
700,803
|
|
|
|
Executive Vice President, Engineering and Chief Technology Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
(1)
|
The amounts reported in this column represent the discretionary amount of annual cash bonuses paid under the Company’s Bonus Plan. For a discussion of the discretionary bonus paid for
2019
, see “
Executive Compensation—Compensation Discussion and Analysis—Components of our Compensation Program—Executive Bonus Plan
.”
|
|
(2)
|
The amounts reported in this column relate to grants of RSUs and PSUs and reflect the aggregate grant date fair value of awards using the closing price of a share of common stock on the grant date computed in accordance with ASC Topic 718 assuming the achievement of the PSUs at the target amount. The grant date fair value of the awards granted during
2018
assuming the achievement of the PSUs at the maximum amounts would be as follows: Mr. Thompson, $8,810,172; Mr. Kalsu, $2,728,306 and Mr. Gardiner, $3,069,360.
|
|
(3)
|
The amounts reported in this column represent the annual cash bonuses paid under the formulaic calculation of the Company’s Bonus Plan for the applicable year. For a detailed discussion of the
2019
Executive Bonus Plan, see “
Executive Compensation—Compensation Discussion and Analysis—Components of our Compensation Program—Executive Bonus Plan
.”
|
|
(4)
|
Unless otherwise noted, consists of employer contribution to NEO’s 401(k) retirement plan.
|
|
(5)
|
While he was on assignment in our United Kingdom office, Mr. Gardiner was entitled to certain specific benefits and allowances based on his expatriate status in order to provide an equalization of his income while working in the United Kingdom to a letter of assignment with us, effective as of July 1, 2017. These benefits and allowances included participation in a specific expatriate health insurance plan, a housing allowance of up to £7,500 per month, a schooling allowance of $3,000 per month, a living allowance of $10,333 per month, a transportation allowance of $1,000 per month, a utilities allowance of $1,500 per month, a travel allowance of $5,000 per quarter, equalization of Mr. Gardiner’s tax liability, and reimbursement of early-return expenses in the event that we terminated Mr. Gardiner’s overseas assignment before August 31, 2018. Amounts paid under these allowances were based on actual expenses.
|
|
(6)
|
Includes $33,449 paid on Mr. Gardiner’s behalf for income taxes due in the United Kingdom in connection with his international assignment, $23,384 paid to tax advisors to assist with Mr. Gardiner’s taxes resulting from his international assignment, $11,200 employer contribution to Mr. Gardiner’s 401(k) retirement plan, tax gross-up for imputed income for the tax preparation benefit and gift card. Amount of the income taxes paid was based on average conversion rate of British Pounds to U.S. Dollars provided by the Bank of England for the entire year ended December 31, 2019.
|
|
(7)
|
Includes relocation expenses, expatriate transportation allowance, $11,000 employer contribution to Mr. Gardiner’s 401(k) retirement plan, $11,250 for expatriate utilities allowance, $12,500 for expatriate travel allowance, $22,500 for expatriate schooling allowance, $77,498 for expatriate cost of living allowance and $78,691 for expatriate housing allowance. Amount of the expatriate housing allowance was based upon the average conversion rate of British Pounds to U.S. Dollars provided by the Bank of England for the entire year ended December 31, 2018.
|
|
(8)
|
Includes employer contribution to Mr. Gardiner’s 401(k) retirement plan, expatriate transportation allowance, expatriate utilities allowance, expatriate travel allowance, $36,000 for expatriate schooling allowance, $73,998 for expatriate cost of living allowance, and $113,933 for expatriate housing allowance, which is based upon the average conversion rate of British Pounds to U.S. Dollars provided by the Bank of England for the entire year ended December 31, 2017.
|
|
(9)
|
Mr. Bliss was not a NEO prior to 2019. Prior to 2019, the Company was an emerging growth company and was required to report compensation for only three NEOs.
|
|
(10)
|
Mr. Kim was not a NEO prior to 2019. Prior to 2019, the Company was an emerging growth company and was required to report compensation for only three NEOs.
|
|
(11)
|
Includes $11,200 employer contribution to Mr. Kim’s 401(k) retirement plan and $50,003 in cash paid to Mr. Kim upon vesting of the contingent right to receive a cash amount equal to the per-share merger consideration received by stockholders in the Take Private into which the unvested RSUs held by Mr. Kim at the time of our Take Private converted in connection with the Take Private.
|
|
Name
|
|
Grant
Date
|
|
Estimated Future
Payouts
Under Non-Equity
Incentive Plan Awards
($)
(1)
|
|
|||||||
|
Threshold ($)
|
|
Target
($)
|
|
Maximum
($)
|
|
|||||||
|
Kevin B. Thompson
|
|
2/19/2019
|
|
306,250
|
|
|
875,000
|
|
|
1,750,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
J. Barton Kalsu
|
|
2/19/2019
|
|
119,000
|
|
|
340,000
|
|
|
680,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
David Gardiner
|
|
2/19/2019
|
|
146,125
|
|
|
417,500
|
|
|
835,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Jason W. Bliss
|
|
2/19/2019
|
|
109,200
|
|
|
312,000
|
|
|
624,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Woong Joseph Kim
|
|
2/19/2019
|
|
109,200
|
|
|
312,000
|
|
|
624,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
(1)
|
Represents the formulaic annual cash bonus under the
2019
Executive Bonus Plan. For a detailed discussion of the performance metrics, weighting and potential payouts under the
2019
Executive Bonus Plan, see above under the caption “
Executive Compensation—Compensation Discussion and Analysis—Components of Our Compensation Program—Executive Bonus Plan
.” For actual amounts paid pursuant to the formulaic calculation under the
2019
Executive Bonus Plan, see “
Executive Compensation Tables—Summary Compensation Table
” above under the column titled “Non-Equity Incentive Plan Compensation.”
|
|
|
|
Stock Awards
|
||||||||||||
|
Name
|
|
Number of Shares or Units of Stock That Have Not Vested (#)
(1)
|
|
Market Value of Shares or Units of Stock That Have Not Vested ($)
(2)
|
|
Equity Incentive Plan Awards: Number of Unearned Shares or Units That Have Not Vested (#)
(3)
|
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares or Units That Have Not Vested ($)
(2)
|
||||||
|
Kevin B. Thompson
|
|
330,000
|
|
(4)
|
|
6,121,500
|
|
|
—
|
|
|
|
—
|
|
|
|
|
79,125
|
|
(5)
|
|
1,467,769
|
|
|
—
|
|
|
|
—
|
|
|
|
|
232,500
|
|
(6)
|
|
4,312,875
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
—
|
|
|
330,000
|
|
(7)
|
|
6,121,500
|
|
|
|
|
—
|
|
|
|
—
|
|
|
206,666
|
|
(8)
|
|
3,833,654
|
|
|
J. Barton Kalsu
|
|
77,000
|
|
(4)
|
|
1,428,350
|
|
|
—
|
|
|
|
—
|
|
|
|
|
31,125
|
|
(5)
|
|
577,369
|
|
|
—
|
|
|
|
—
|
|
|
|
|
72,000
|
|
(6)
|
|
1,335,600
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
—
|
|
|
77,000
|
|
(7)
|
|
1,428,350
|
|
|
|
|
—
|
|
|
|
—
|
|
|
64,000
|
|
(8)
|
|
1,187,200
|
|
|
David Gardiner
|
|
70,000
|
|
(4)
|
|
1,298,500
|
|
|
—
|
|
|
|
—
|
|
|
|
|
67,500
|
|
(5)
|
|
1,252,125
|
|
|
—
|
|
|
|
—
|
|
|
|
|
81,000
|
|
(6)
|
|
1,502,550
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
—
|
|
|
70,000
|
|
(7)
|
|
1,298,500
|
|
|
|
|
—
|
|
|
|
—
|
|
|
72,000
|
|
(8)
|
|
1,335,600
|
|
|
Jason W. Bliss
|
|
50,600
|
|
(4)
|
|
938,630
|
|
|
—
|
|
|
|
—
|
|
|
|
|
46,500
|
|
(5)
|
|
862,575
|
|
|
—
|
|
|
|
—
|
|
|
|
|
57,000
|
|
(6)
|
|
1,057,350
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
—
|
|
|
50,600
|
|
(7)
|
|
938,630
|
|
|
|
|
—
|
|
|
|
—
|
|
|
50,666
|
|
(8)
|
|
939,854
|
|
|
Woong Joseph Kim
|
|
30,000
|
|
(4)
|
|
556,500
|
|
|
|
|
|
—
|
|
|
|
|
|
46,875
|
|
(5)
|
|
869,531
|
|
|
|
|
|
—
|
|
|
|
|
|
57,000
|
|
(6)
|
|
1,057,350
|
|
|
|
|
|
—
|
|
|
|
|
|
30,000
|
|
(9)
|
|
556,500
|
|
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
—
|
|
|
30,000
|
|
(7)
|
|
556,500
|
|
|
|
|
—
|
|
|
|
—
|
|
|
50,666
|
|
(8)
|
|
939,854
|
|
|
|
|
—
|
|
|
|
—
|
|
|
30,000
|
|
(10)
|
|
556,500
|
|
|
(1)
|
The stock awards reported in this column represent the unvested portion of outstanding restricted stock awards or RSUs subject to time-based vesting conditions.
|
|
(2)
|
Calculated based on the closing price of our common stock as listed on the NYSE on
December 31, 2019
, which was $
18.55
per share.
|
|
(3)
|
The stock awards reported in this column represent the unvested portion of outstanding restricted stock awards and PSUs subject to performance-based vesting conditions.
|
|
(4)
|
Represents unvested portion of restricted stock award that vests in equal annual installments over five years on each anniversary of February 5, 2016, subject to continued employment through each applicable vesting date. Our NEOs paid a purchase price of $0.2706 per share. The unvested shares of restricted stock held by our NEOs are subject to repurchase by us upon termination of employment at the lesser of fair market value and original purchase price of such stock.
|
|
(5)
|
Represents unvested portion of restricted stock award that vests in equal annual installments over four years on each anniversary of March 20, 2018, subject to continued employment through each applicable vesting date. Our NEOs paid a purchase price of $2.10 per share. The unvested shares of restricted stock held by our NEOs are subject to repurchase by us upon termination of employment at the lesser of fair market value and original purchase price of such stock.
|
|
(6)
|
Represents RSUs that vest in equal annual installments over four years on each anniversary of October 23, 2018, subject to continued employment through each applicable vesting date.
|
|
(7)
|
Represents unvested portion of restricted stock award that vests in equal annual installments over five years after the end of each of fiscal years 2016 through 2020 provided that specified performance targets set by our Board or compensation committee are achieved for the applicable fiscal year, subject to continued employment through each applicable vesting date. Our NEOs paid a purchase price of $0.2706 per share. The unvested shares of
|
|
(8)
|
Represents PSUs at target amounts to be earned based on performance against specified performance targets set by our Board or compensation committee for fiscal year 2019. Earned PSUs vest in equal annual installments on each of the date that our compensation committee certifies that the applicable performance measures have been achieved, February 1, 2021 and February 1, 2022, subject to continued employment through each applicable vesting date. For a detailed discussion of these PSUs, see above under the caption “
Executive Compensation—Compensation Discussion and Analysis—Components of Our Compensation Program—Long-Term Incentives—Prior Year Equity Awards
.”
|
|
(9)
|
Represents unvested portion of restricted stock award that vests in equal annual installments over five years on each anniversary of September 18, 2017 subject to continued employment through each applicable vesting date. Mr. Kim paid a purchase price of $0.74 per share. The unvested shares of restricted stock held by Mr. Kim are subject to repurchase by us upon termination of employment at the lesser of fair market value and original purchase price of such stock.
|
|
(10)
|
Represents unvested portion of restricted stock award that vests in equal annual installments over five years after the end of each of fiscal years 2017 through 2021 provided that specified performance targets set by our Board or compensation committee are achieved for the applicable fiscal year, subject to continued employment through each applicable vesting date. Mr. Kim paid a purchase price of $0.74 per share. The unvested shares of restricted stock held by Mr. Kim are subject to repurchase by us upon termination of employment or failure to achieve the performance targets at the lesser of fair market value and original purchase price of such stock. For a detailed discussion of the performance objectives for 2019 applicable to these awards, see above under the caption “
Executive Compensation—Compensation Discussion and Analysis—Components of Our Compensation Program—Long-Term Incentives—Prior Year Equity Awards.
”
|
|
Name
|
|
Option Awards
|
|
Stock Awards
|
||||||||
|
Number of Shares Acquired on Exercise
(#)
|
|
Value Realized on Exercise
($)
|
|
Number of Shares Acquired on Vesting
(#) |
|
Value Realized on Vesting
($) |
||||||
|
Kevin B. Thompson
|
|
—
|
|
|
—
|
|
|
433,875
|
|
|
7,969,900
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
J. Barton Kalsu
|
|
—
|
|
|
—
|
|
|
111,375
|
|
|
2,045,181
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
David Gardiner
|
|
—
|
|
|
—
|
|
|
119,500
|
|
|
2,184,628
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Jason W. Bliss
|
|
—
|
|
|
—
|
|
|
85,100
|
|
|
1,556,086
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Woong Joseph Kim
|
|
—
|
|
|
—
|
|
|
84,625
|
|
|
1,549,785
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
•
|
“Cause” means any of the following: (i) the executive’s continued substantial violations of the executive’s employment duties or willful disregard of commercially reasonable and lawful directives from the Board (in the case of Mr. Thompson) or the managing executive (in the case of our other NEOs), after the executive has received a written demand for performance from the Board that sets forth the factual basis for the Company’s belief that the executive has not substantially performed the executive’s duties or willfully disregarded directives from the Board (in the case of Mr. Thompson) or the managing executive (in the case of our other NEOs); (ii) the executive’s moral turpitude, dishonesty or gross misconduct
|
|
•
|
“Constructive termination” means a termination in which the Company, without the executive’s express written consent, either (i) materially reduces the powers and duties of employment of the executive resulting in a material decrease in the responsibilities of the executive, (ii) materially reduces the pay of the executive, (iii) requires a material change in the geographic location of the executive’s primary work facility or location, or (iv) with respect to Mr. Thompson, fails to provide directors’ and officers’ liability insurance covering Mr. Thompson during the term of his employment (which failure would be a material breach of the employment agreement), and due to such act or event the executive terminates his employment with the Company within thirty (30) days following the expiration of a 30-day Company cure period.
|
|
•
|
“Change in control,” for purposes of Mr. Thompson’s employment agreement, is as defined in our stockholders’ agreement. “Change in control,” for purposes of the employment agreements with our other NEOs, means a transaction or series of transactions where the shareholders of the Company (or those of its ultimate parent entity) immediately preceding such transaction own, following such transaction, less than 50% of the voting securities of the Company; provided however, that a firmly underwritten public offering of the Common Stock shall not be deemed a change in control.
|
|
•
|
a lump-sum cash severance payment equivalent to 18 months of his then-current base salary (or 24 months in the event the termination is during the 12-month period after a change in control);
|
|
•
|
reimbursement of his and his dependents’ health and dental care continuation premiums for 18 months (or 24 months in the event the termination is during the 12-month period after a change in control); and
|
|
•
|
any earned but unpaid bonus payments for the year in which the termination occurs, on a pro rata basis, based on the level at which the Board determines that the applicable performance objectives are reasonably likely to be satisfied.
|
|
•
|
a lump-sum cash severance payment equivalent to 12 months of his then-current base salary;
|
|
•
|
reimbursement of his and his dependents’ health and dental care continuation premiums for 12 months;
|
|
•
|
any earned but unpaid bonus payments; and
|
|
•
|
payment of any contingent right to receive a cash amount equal to the per-share merger consideration received by stockholders in the Take Private into which the unvested RSUs held by our NEOs converted in connection with the Take Private due upon vesting within six months of the effective date of termination.
|
|
|
|
|
|
|
|
|
|
Termination without
Change in Control
|
|
Termination upon
Change in Control
|
|||||||||||
|
|
|
Death
($)
|
|
For Cause /
Voluntary Termination / Disability
($)
|
|
Change of Control
($)
|
|
Other than For Cause Termination
($)
|
|
Constructive Termination
($)
|
|
Other than For Cause Termination
($) |
|
Constructive Termination
($) |
|||||||
|
Kevin B. Thompson
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Cash Severance
(1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,005,000
|
|
|
1,005,000
|
|
|
1,400,000
|
|
|
1,400,000
|
|
|
Bonus
(2)
|
|
875,000
|
|
|
—
|
|
|
—
|
|
|
875,000
|
|
|
875,000
|
|
|
875,000
|
|
|
875,000
|
|
|
Medical Benefits
(3)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
33,670
|
|
|
33,670
|
|
|
44,893
|
|
|
44,893
|
|
|
Equity Acceleration
(4)
|
|
—
|
|
|
—
|
|
|
12,243,000
|
|
|
—
|
|
|
—
|
|
|
12,243,000
|
|
|
12,243,000
|
|
|
Estimated Total
|
|
875,000
|
|
|
—
|
|
|
12,243,000
|
|
|
1,958,670
|
|
|
1,958,670
|
|
|
14,562,893
|
|
|
14,562,893
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
J. Barton Kalsu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Cash Severance
(1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
425,000
|
|
|
—
|
|
|
425,000
|
|
|
425,000
|
|
|
Bonus
(2)
|
|
340,000
|
|
|
—
|
|
|
—
|
|
|
340,000
|
|
|
—
|
|
|
340,000
|
|
|
340,000
|
|
|
Medical Benefits
(3)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22,446
|
|
|
—
|
|
|
22,446
|
|
|
22,446
|
|
|
Equity Acceleration
(4)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,956,869
|
|
|
5,956,869
|
|
|
Estimated Total
|
|
340,000
|
|
|
—
|
|
|
—
|
|
|
787,446
|
|
|
—
|
|
|
6,744,315
|
|
|
6,744,315
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
David Gardiner
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Cash Severance
(1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
417,500
|
|
|
—
|
|
|
417,500
|
|
|
417,500
|
|
|
Bonus
(2)
|
|
417,500
|
|
|
—
|
|
|
—
|
|
|
417,500
|
|
|
—
|
|
|
417,500
|
|
|
417,500
|
|
|
Medical Benefits
(3)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22,446
|
|
|
—
|
|
|
22,446
|
|
|
22,446
|
|
|
Equity Acceleration
(4)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,687,275
|
|
|
6,687,275
|
|
|
Estimated Total
|
|
417,500
|
|
|
—
|
|
|
—
|
|
|
857,446
|
|
|
—
|
|
|
7,544,721
|
|
|
7,544,721
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Jason W. Bliss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Cash Severance
(1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
390,000
|
|
|
—
|
|
|
390,000
|
|
|
390,000
|
|
|
Bonus
(2)
|
|
312,000
|
|
|
—
|
|
|
—
|
|
|
312,000
|
|
|
—
|
|
|
312,000
|
|
|
312,000
|
|
|
Medical Benefits
(3)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22,351
|
|
|
—
|
|
|
22,351
|
|
|
22,351
|
|
|
Equity Acceleration
(4)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,737,039
|
|
|
4,737,039
|
|
|
Estimated Total
|
|
312,000
|
|
|
—
|
|
|
—
|
|
|
724,351
|
|
|
—
|
|
|
5,461,390
|
|
|
5,461,390
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Woong Joseph Kim
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Cash Severance
(1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
390,000
|
|
|
—
|
|
|
390,000
|
|
|
390,000
|
|
|
Bonus
(2)
|
|
312,000
|
|
|
—
|
|
|
—
|
|
|
312,000
|
|
|
—
|
|
|
312,000
|
|
|
312,000
|
|
|
Medical Benefits
(3)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,561
|
|
|
—
|
|
|
12,561
|
|
|
12,561
|
|
|
Equity Acceleration
(4)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,142,739
|
|
|
5,142,739
|
|
|
Estimated Total
|
|
312,000
|
|
|
—
|
|
|
—
|
|
|
714,561
|
|
|
—
|
|
|
5,857,300
|
|
|
5,857,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
(1)
|
This amount represents the lump sum cash severance amount payable under our employment agreements with our NEOs based on base salary as of
December 31, 2019
.
|
|
(2)
|
This amount represents the formulaic annual cash bonus under the
2019
Executive Bonus Plan. For purposes of this disclosure, achievement is assumed to be 100% of the target level, but actual achievement may vary. The compensation committee’s certification of achievement for the
2019
Executive Bonus Plan was completed in the first quarter of 2020. For actual achievement level for fiscal year
2019
, see above under the caption “
Executive Compensation—Compensation Discussion and Analysis—Components of Our Compensation Program—Executive Bonus Plan
.” For actual amount paid under the formulaic annual cash bonus under the
2019
Executive Bonus Plan, see above under “
Executive Compensation Tables—Summary Compensation Table
” in the column titled “Non-Equity Incentive Plan Compensation.”
|
|
(3)
|
Calculated based on the premiums payable to elect benefit continuation coverage by the NEO pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, (COBRA) for the applicable continuation period, and for the actual level of group medical, dental and vision coverage in effect as of
December 31, 2019
.
|
|
(4)
|
For Mr. Thompson, this amount consists of full acceleration of certain unvested restricted stock held by Mr. Thompson as of
December 31, 2019
calculated based on the closing price of our common stock as listed on the NYSE on
December 31, 2019
, which was $
18.55
per share. For other NEOs, this amount includes the full acceleration of all outstanding unvested restricted stock, RSUs and PSUs held by the NEO as of
December 31, 2019
calculated based on the closing price of our common stock as listed on the NYSE on
December 31, 2019
, which was $
18.55
per share. For purposes of this disclosure, achievement
|
|
•
|
change in control transactions;
|
|
•
|
acquiring or disposing of assets or entering into joint ventures with a value in excess of $300.0 million;
|
|
•
|
incurring indebtedness in an aggregate principal amount in excess of $300.0 million;
|
|
•
|
initiating any liquidation, dissolution, bankruptcy or other insolvency proceeding involving the Company or any of our significant subsidiaries;
|
|
•
|
increasing or decreasing the size of our Board; and
|
|
•
|
terminating the employment of our chief executive officer or hiring a new chief executive officer.
|
|
•
|
for any breach of a duty of loyalty to us or our stockholders;
|
|
•
|
for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law;
|
|
•
|
for any transaction from which the director derived an improper benefit; or
|
|
•
|
for an act or omission for which the liability of a director is expressly provided by an applicable statute, including unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the DGCL.
|
|
Name of Beneficial Owner
|
|
Number of Shares Beneficially Owned
|
|
Percentage of Common Stock Outstanding
|
||
|
Named Executive Officers and Directors:
|
|
|
|
|
||
|
Kevin B. Thompson
(1)
|
|
2,844,789
|
|
|
*
|
|
|
J. Barton Kalsu
(2)
|
|
605,927
|
|
|
*
|
|
|
David Gardiner
(3)
|
|
563,023
|
|
|
*
|
|
|
Jason W. Bliss
(4)
|
|
367,895
|
|
|
*
|
|
|
Woong Joseph Kim
(5)
|
|
331,287
|
|
|
*
|
|
|
Michael Bingle
|
|
18,518
|
|
|
*
|
|
|
William Bock
|
|
18,518
|
|
|
*
|
|
|
Seth Boro
|
|
18,518
|
|
|
*
|
|
|
Paul J. Cormier
|
|
18,518
|
|
|
*
|
|
|
Kenneth Y. Hao
|
|
18,518
|
|
|
*
|
|
|
Michael Hoffmann
|
|
18,518
|
|
|
*
|
|
|
Catherine R. Kinney
|
|
18,518
|
|
|
*
|
|
|
James Lines
(6)
|
|
73,523
|
|
|
*
|
|
|
Easwaran Sundaram
|
|
—
|
|
|
—
|
|
|
Michael Widmann
|
|
—
|
|
|
—
|
|
|
All executive officers and directors as a group (16 persons)
(7)
|
|
5,138,613
|
|
|
1.7
|
%
|
|
5% Stockholders:
|
|
|
|
|
||
|
Silver Lake Funds
(8)
|
|
130,116,606
|
|
|
41.7
|
%
|
|
Thoma Bravo Funds
(9)
|
|
106,020,448
|
|
|
34.0
|
%
|
|
Thoma Bravo Co-Investors
(10)
|
|
24,143,258
|
|
|
7.7
|
%
|
|
AlpInvest Partners
(11)
|
|
5,248,536
|
|
|
1.7
|
%
|
|
HarbourVest Partners
(12)
|
|
7,872,801
|
|
|
2.5
|
%
|
|
Hermes USA Investors Venture II LP
(13)
|
|
1,049,707
|
|
|
*
|
|
|
Howard Hughes Medical Institute
(14)
|
|
524,853
|
|
|
*
|
|
|
Lexington Co-Investment Holdings III L.P.
(15)
|
|
2,624,268
|
|
|
*
|
|
|
NB Alternatives Advisers LLC
(16)
|
|
5,248,533
|
|
|
*
|
|
|
Prudential
(17)
|
|
1,574,560
|
|
|
*
|
|
|
*
|
Represents beneficial ownership of less than 1%.
|
|
(1)
|
Includes 432,250 shares of restricted stock subject to vesting conditions that will not vest within 60 days of
March 31, 2020
, as well as 186,250 shares of common stock held by Mr. Thompson
’
s children. Mr. Thompson may be deemed to have shared voting and investment power with respect to all of the shares of restricted stock held by his children.
|
|
(2)
|
Includes 109,300 shares of restricted stock subject to vesting that will not vest within 60 days of
March 31, 2020
.
|
|
(3)
|
Includes 125,500 shares of restricted stock subject to vesting that will not vest within 60 days of
March 31, 2020
.
|
|
(4)
|
Includes 89,190 shares of restricted stock subject to vesting that will not vest within 60 days of
March 31, 2020
.
|
|
(5)
|
Includes 118,750 shares of restricted stock subject to vesting that will not vest within 60 days of
March 31, 2020
.
|
|
(6)
|
Includes 7,500 shares of restricted stock subject to vesting that will not vest within 60 days of
March 31, 2020
.
|
|
(7)
|
Includes 958,290 shares of restricted stock subject to vesting conditions that will not vest within 60 days of
March 31, 2020
beneficially owned by our executive officers and directors.
|
|
(8)
|
Consists of 91,879,985 shares of common stock held directly by Silver Lake Partners IV, L.P., the general partner of which is Silver Lake Technology Associates IV, L.P., or SLTA IV, the general partner of which is SLTA IV (GP), L.L.C., or SLTA GP IV; 1,510,161 shares of common stock held directly by Silver Lake Technology Investors IV, L.P., the general partner of which is SLTA IV; and 36,726,460 shares of common stock held directly by SLP Aurora Co-Invest, L.P., the general partner of which is SLP Denali Co-Invest GP, L.L.C., the managing member of which is Silver Lake Technology Associates III, L.P., the general partner of which is SLTA III (GP), L.L.C., or SLTA GP III. Silver Lake Group, L.L.C., or SLG, is the managing member of each of SLTA GP IV and SLTA GP III. The address of each of the entities identified in this footnote is c/o Silver Lake, 2775 Sand Hill Road, Suite 100, Menlo Park, California 94025.
|
|
(9)
|
Includes 34,570,393 shares of common stock held directly by Thoma Bravo Fund XI, L.P., 17,362,105 shares of common stock held directly by Thoma Bravo Fund XI-A, L.P., 17,101,107 shares of common stock held directly by Thoma Bravo Fund XII, L.P., 15,123,756 shares of common stock held directly by Thoma Bravo Fund XII-A, L.P., 762,656 shares of common stock held directly by Thoma Bravo Executive Fund XI, L.P., 167,358 shares of common stock held directly by Thoma Bravo Executive Fund XII, L.P., 148,711shares of common stock held directly by Thoma Bravo Executive Fund XII-a, L.P., 13,991,825 shares of common stock held directly by Thoma Bravo Special Opportunities Fund XII, L.P., and 6,792,537 shares of common stock held directly by Thoma Bravo Special Opportunities Fund XII-A, L.P. Thoma Bravo Partners XI, L.P., or TB Partners XI, is the general partner of each of Thoma Bravo Fund XI, L.P., Thoma Bravo Fund XI-A, L.P., Thoma Bravo Special Opportunities Fund II, L.P., Thoma Bravo Special Opportunities Fund II-A, L.P. and Thoma Bravo Executive Fund XI, L.P. Thoma Bravo Partners XII, L.P., or TB Partners XII, is the general partner of each of Thoma Bravo Fund XII, L.P., Thoma Bravo Fund XII-A, L.P., Thoma Bravo Executive Fund XII, L.P. and Thoma Bravo Executive Fund XII-a, L.P. Thoma Bravo is the general partner of each of TB Partners XI and TB Partners XII. By virtue of the relationships described in this footnote, Thoma Bravo may be deemed to exercise shared voting and dispositive power with respect to the shares held by the Thoma Bravo Funds. The principal business address of the entities identified herein is c/o Thoma Bravo, LLC,150 North Riverside Plaza, Suite 2800, Chicago, Illinois 60606.
|
|
(10)
|
By virtue of the stockholder
s’
agreement, Thoma Bravo may be deemed to exercise voting and dispositive power with respect to the shares held by the stockholders listed below. Thoma Bravo disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest, if any.
|
|
(11)
|
Includes 62,982 shares of common stock held directly by AlpInvest GA Co C.V., 4,345,789 shares of common stock held directly by AlpInvest Partners Co-Investments 2014 I C.V., 704,353 shares of common stock held directly by AlpInvest Partners Co-Investments 2014 II C.V. and 135,412 shares of common stock held directly by AM 2014 Co C.V. Ultimate voting and dispositive power with respect to the shares held by the foregoing entities is exercised by AlpInvest Partners B.V. The principal business address for each of the entities identified herein is Jachthavenweg 118, 1081 KJ Amsterdam, the Netherlands.
|
|
(12)
|
Includes 314,912 shares of common stock held directly by HarbourVest 2015 Global Fund L.P., 472,368 shares of common stock held directly by HarbourVest Global Annual Private Equity Fund L.P., 1,312,133 shares of common stock held directly by HarbourVest Partners IX-Buyout Fund L.P., 314,912 shares of common stock held directly by HarbourVest Partners X AIF Buyout L.P., 734,795shares of common stock held directly by HarbourVest Partners X Buyout Fund L.P., 524,853 shares of common stock held directly by Meranti Fund L.P., 524,853 shares of common stock held directly by NPS Co-Investment (A) Fund L.P. and 3,673,975 shares of common stock held directly by SMRS-TOPE LLC. Ultimate voting and dispositive power with respect to the shares held by the foregoing entities is exercised by HarbourVest Partners, LLC. The principal business address of each of the entities identified herein is One Financial Center, 44th Floor, Boston, MA 02111.
|
|
(13)
|
Ultimate voting and dispositive power with respect to the shares held by Hermes USA Investors Venture II LP is exercised by Hermes GPE LLP, acting in its capacity as manager of such stockholder. The principal business address for the stockholder is c/o Hermes GPE LLP.
|
|
(14)
|
Howard Hughes Medical Institute (“HHMI”) is a nonprofit Delaware corporation qualified under 501(c)(3) of the Code and has no stockholders or beneficial owners. Voting and dispositive power with respect to the shares held by HHMI is exercised by Landis Zimmerman, as Chief Investment Officer. The principal business address of HHMI is 4000 Jones Bridge Road, Chevy Chase, MD 20815.
|
|
(15)
|
CIP Partners III, L.P. is the general partner of Lexington Co-Investment Holdings III, L.P. CIP Partners GP III LLC is the general partner of CIP Partners III, L.P. Lexington Partners L.P. is the managing member of CIP Partners GP III LLC. Lexington Partners Advisors GP L.L.C. is the general partner of Lexington Partners L.P. Lexington Partners Advisors Holdings L.P. is the sole member of Lexington Partners Advisors GP L.L.C. Lexington Partners Advisors Holdings GP L.L.C. is the general partner of Lexington Partners Advisors Holdings L.P. Ultimate voting and dispositive power of Lexington Partners Advisors Holdings GP L.L.C. is exercised by Brent R. Nicklas who disclaims beneficial ownership of the shares. The principal business address of the stockholder is 660 Madison Avenue, 23rd Floor, New York, NY 10065
|
|
(16)
|
Includes 419,882 shares of common stock held directly by NB Crossroads XX - MC Holdings LP, 157,455 shares of common stock held directly by NB Crossroads XXI - MC Holdings LP, 104,971 shares of common stock held directly by NB - Iowa’s Public Universities LP, 367,397 shares of common stock held directly by NB PEP Holdings Limited, 104,971 shares of common stock held directly by NB RP Co-Investment & Secondary Fund LLC, 104,971 shares of common stock held directly by NB Sonoran Fund Limited Partnership, 3,149,121 shares of common stock held directly by NB Strategic Co-Investment Partners II Holdings LP, 104,971 shares of common stock held directly by NB Wildcats Fund LP, 209,941 shares of common stock held directly by Neuberger Berman Insurance Fund Series Interests of the SALI Multi-Series Fund L.P. and 524,853 shares of common stock held directly by TfL Trustee Company Limited as Trustee of the TfL Pension Fund. Ultimate voting and dispositive power with respect to the shares held by the foregoing entities is exercised by NB Alternatives Advisers LLC. The principal business address for each of the entities identified herein is 325 N. Saint Paul Street, Suite 4900, Dallas, TX 75201.
|
|
(17)
|
Includes 787,280 shares of common stock held directly by The Prudential Insurance Company of America and 787,280 shares of common stock held directly by the Prudential Legacy Insurance Company of New Jersey. Ultimate voting and dispositive power with respect to the shares held by the foregoing entities is exercised by Prudential Financial, Inc. The principal business address for each of the entities identified herein is 751 Broad Street, Newark, New Jersey 07102.
|
|
|
Number of Securities to Be Issued Upon Exercise of Outstanding Options, Warrants and Rights
|
|
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights
|
|
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plan (excluding securities reflected in column (a))
|
|
||||
|
Equity compensation plans approved by security holders
|
9,228,028
|
|
(1)
|
$
|
1.69
|
|
(2)
|
25,497,540
|
|
(3)
|
|
Equity compensation plans not approved by security holders
|
503,707
|
|
(4)
|
—
|
|
|
—
|
|
|
|
|
Total
|
9,731,735
|
|
|
$
|
1.69
|
|
|
25,497,540
|
|
|
|
(1)
|
Includes 2,105,825 shares subject to outstanding options under the 2016 Plan, 6,118,177 shares subject to RSUs, granted under the 2018 Plan and 1,004,026 shares subject to PSUs granted under the 2018 Plan at the target award amounts. Based on the extent to which the applicable performance measures are achieved, shares issued upon vesting of the outstanding PSUs may range from 0% - 150% of the target award amounts. Excludes restricted stock issued under the 2016 Plan, whether vested or unvested.
|
|
(2)
|
RSUs and PSUs that do not have an exercise price, are excluded in the calculation of weighted average exercise price.
|
|
(3)
|
As of
December 31, 2019
, an aggregate of (i) 21,822,569 shares of common stock were available for issuance under the 2018 Plan and (ii) 3,674,971 shares of common stock were available for issuance under the 2018 Purchase Plan. Our ability to grant any future equity awards under the 2016 Plan was terminated in October 2018. Outstanding equity awards granted under the 2016 Plan prior to October 2018 remain subject to the terms of the 2016 Plan.
|
|
(4)
|
Includes RSUs granted outside any equity plan related to certain outstanding unvested options to purchase shares of acquired companies that were cancelled and converted into RSUs subject to substantially the same vesting schedules and other conditions applicable to the unvested options, but settable solely in shares of common stock of the Company.
|
|
|
VOTE BY INTERNET
Before The Meeting
- Go to
www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.
During The Meeting
- Go to
www.virtualshareholdermeeting.com/SWI2020
You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.
|
|
|
|
|
|
|
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the meeting date. Have your proxy card in hand when you call and then follow the instructions.
|
|
|
|
|
|
|
|
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
|
|
|
D05326-P34651
|
KEEP THIS PORTION FOR YOUR RECORDS
|
|
|
DETACH AND RETURN THIS PORTION ONLY
|
|
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
|
|
|
|
For
All
|
|
Withhold
All
|
|
For All
Except
|
|
To withhold authority to vote for any individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below.
|
|
|
|||||||||||||||
|
|
The Board of Directors recommends you vote FOR the following:
|
o
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
1.
|
Election of Class II Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
Nominees:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
01)
|
Catherine R. Kinney
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
02)
|
James Lines
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
03)
|
Easwaran Sundaram
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
04)
|
Michael Widmann
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends that you vote FOR the following proposal:
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
|
|||||||||||||
|
|
2.
|
Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.
|
|
o
|
|
o
|
|
o
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
The Board of Directors recommends ONE year for the following proposal:
|
|
ONE Year
|
|
TWO Years
|
|
THREE Years
|
|
Abstain
|
|||||||||||||||
|
|
3.
|
Advisory vote on the frequency of future advisory votes on executive compensation.
|
|
o
|
|
o
|
|
o
|
|
o
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
NOTE:
|
In their discretion, the proxies are authorized to vote on such other business as may properly come before the meeting or any adjournment thereof.
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
|
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
Signature [PLEASE SIGN WITHIN BOX]
|
|
Date
|
|
|
|
Signature (Joint Owners)
|
|
Date
|
|
|
|
|
|||||||||||
|
|
|
|
|
D05327-P34651
|
|
|
|
|
|
SOLARWINDS CORPORATION
|
||
|
Annual Meeting of Shareholders
|
||
|
May 21, 2020 9:00 AM, Central Time
|
||
|
This proxy is solicited by the Board of Directors
|
||
|
|
||
|
The shareholder(s) hereby appoint(s) Kevin B. Thompson and J. Barton Kalsu or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of common stock of SOLARWINDS CORPORATION that the shareholder(s) are entitled to vote at the Annual Meeting of Shareholder(s) to be held virtually at
www.virtualshareholdermeeting.com/SWI2020
at 9:00 AM, Central Time on May 21, 2020, and any adjournment or postponement thereof.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors' recommendations.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
Continued and to be signed on reverse side
|
||
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|